Navigation Links
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call
Date:7/1/2008

PRINCETON, N.J., July 1 /PRNewswire-FirstCall/ -- In conjunction with its second quarter 2008 earnings release (expected to be issued after market close on July 30), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, July 31, 2008 at 9:00 a.m. ET.

What: Covance Second Quarter 2008 Earnings Webcast and Slide

Presentation

When: July 31, 2008, 9:00 a.m. ET*

Where: http://www.covance.com

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

*If you are unable to participate during the live webcast, the event will be archived on the web site http://www.covance.com for 14 days.


'/>"/>
SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Covance to Present at the William Blair Growth Stock Conference
2. Covance Elects Joseph C. Scodari to Companys Board of Directors
3. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
4. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
5. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
6. Covance to Present at UBS Global Healthcare Services Conference
7. Covance to Present at 26th Annual JPMorgan Healthcare Conference
8. Wendel Barr Appointed Chief Operating Officer of Covance
9. Covance and Care Partner on Rwanda Early Childhood Development Initiative
10. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
11. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... Guide to ... , No matter on which side of the Atlantic devicemakers do business, ... regulations they have to follow. , In addition to the full text of the ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s ... mid-market executives as a kick-off to the fifth annual CEO Connection Mid-Market Convention. ... the University of Pennsylvania campus, followed by the two-day convention, which will target ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: